本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Crescent Biopharma Inc

16.77
-0.4100-2.39%
盤後16.770.00000.00%16:10 EDT
成交量:66.59萬
成交額:1,127.63萬
市值:6.23億
市盈率:-2.26
高:18.57
開:17.60
低:16.32
收:17.18
52周最高:27.41
52周最低:8.72
股本:3,714.39萬
流通股本:1,595.35萬
量比:2.04
換手率:4.17%
股息:- -
股息率:- -
每股收益(TTM):-7.4105
每股收益(LYR):-12.8150
淨資產收益率:-160.75%
總資產收益率:-69.15%
市淨率:8.59
市盈率(LYR):-1.31

資料載入中...

2022/05/02

[修訂]年度報告

10-K/A [Amend] - Annual report [Section 13 and 15(d), not S-K Item 405]
2022/04/21

超過5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2022/04/05

重要事件披露

8-K - Current report
2022/03/31

年度報告

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2022/03/31

員工持股計劃

S-8 - Securities to be offered to employees in employee benefit plans
2022/03/16

重要事件披露

8-K - Current report
2022/03/16

超過5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2022/03/07

超過5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2022/03/04

超過5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2022/02/28

超過5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2022/02/23

超過5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2022/02/18

重要事件披露

8-K - Current report
2022/02/14

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2022/02/14

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2022/02/14

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2022/02/11

超過5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2022/01/27

超過5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2022/01/25

重要事件披露

8-K - Current report
2022/01/12

重要事件披露

8-K - Current report
2022/01/05

超過5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership